SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech failure, 2002 -- Ignore unavailable to you. Want to Upgrade?


To: Alfred W. Post who wrote (79)6/10/2002 2:21:19 PM
From: mopgcw  Read Replies (1) | Respond to of 130
 
The whole rebif/avonex battle was hardly a contest of one superior product over another as you put forth. Both Serono and Biogen are guilty of PR science on this one and should be ashamed. Serono's claim of superiority is suspect and Biogen's vigorous defense of orphan status against a potentially improved treatment does not endear it to patients. it is an ugly episode.